Jakub Adam Gołąb
age 54Currently 1 role in 1 KRS entity. In the KRS since 2019.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
Explorna Therapeutics sp. z o.o. |
since May 16, 2019 | ul. Żwirki I Wigury 93/2157, 02-089 Warszawa |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Share capital increased | Share capital: 8 350 zł → 9 100 zł Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: 7 600 zł → 8 350 zł Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Left | Partner (8.76% of shares worth PLN 600) Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: 6 850 zł → 7 600 zł Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Shareholding changed | Partner: 10% of shares worth PLN 500 → 8.76% of shares worth PLN 600 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: 6 250 zł → 6 850 zł Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: 5 000 zł → 6 250 zł Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Company founded | Management Board Member, Partner (10% of shares worth PLN 500) Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Risk signals
| Signal | Details |
|---|---|
Politically exposed person (PEP) | None |
Person on a sanctions list | None |
Bankruptcy or restructuring | None |
Liquidation | None |
Sanctions list | None |
Inactive entity | None |
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Jacek Jemielityage 53 | Explorna Therapeutics sp. z o.o. | since May 16, 2019 | |
Mateusz Michał Gołąbage 53 | Explorna Therapeutics sp. z o.o. | since Jan 15, 2021 | |
Tomasz Piecage 57 | Explorna Therapeutics sp. z o.o. | since Jan 15, 2021 |